| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |